BioCentury
ARTICLE | Clinical News

Cidofovir: Partner Storz Instrument Co. began a 48-patient, placebo-controlled Phase I study

January 8, 1996 8:00 AM UTC

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: Cidofovir, small molecule nucleotide analog Indication: External eye infections Status: Partner Storz Instrument Co., a subsidiary of America...